Clinerion Partners with MEDSOFT to Expand Clinical Research in Georgia
Clinerion will offer its services to hospitals in Georgia, bringing them access to international clinical studies and the use of Patient Network Explorer for academic research. Georgian Medical Software – MEDSOFT, an EHR supplier, will support Clinerion in expanding its footprint in Georgia.
Georgian Medical Software – MEDSOFT, an EHR systems supplier with 10 years’ experience in eHealth in Tbilisi, Georgia, supports hospitals and the medical community with innovative technology and dedicated services. More than 40 hospitals and medical centers in Georgia use MEDSOFT’s software. Their MEDWORK hospital information system (HIS) is integrated with the Georgian Ministry of Health, financial systems, and laboratory information systems, allowing costless and effective information management for the healthcare community.
As part of their partnership, MEDSOFT will support Clinerion in integrating hospitals in Georgia in Clinerion’s international network of partner hospitals on its Patient Network Explorer platform.
In turn, MEDSOFT hospitals will be able to use Patient Network Explorer’s real-world data solutions when running academic research. They will gain sophisticated tools to query their own HIS, allowing them to review and optimize protocols, and find and identify eligible patients for trials within their own hospitals. Joining the Patient Network Explorer platform will also make these hospitals visible to pharmaceutical companies seeking trial sites for clinical research of drugs in development.
“Our System, MEDWORK, was developed with an easy-to-use interface and has the functionality and capability to fully provide support for the processes of receiving, keeping and processing data in any type of medical institution,” says Archil Kapanadze, CEO of MEDSOFT. “This system uses latest and renewable programing technologies. We provide about 25% new features and capabilities annually for our customers.”
“As a HIS provider with a strong presence in Georgia, we consider MEDSOFT an important partner in our expansion in the region, enabling Clinerion to reach more patients” says Ian Rentsch, CEO of Clinerion. “Added to that is their strong technology capability, which ensures smooth integration of new hospital partners to Patient Network Explorer.”
About Clinerion
Clinerion accelerates clinical research and medical access to treatments for patients. We use proprietary technologies for analysis of patient data from our global network of partner hospitals. Clinerion's Patient Network Explorer radically improves the efficiency and effectiveness of clinical trial recruitment by offering data-driven protocol optimization, site feasibility evaluation and real-time patient search and identification to match patients to treatments. Our technology solution provides real-world evidence analytics for medical access. Clinerion facilitates the participation of partner hospitals in leading-edge, industry-sponsored trials and time savings in patient recruitment. We create innovative and disruptive fit-for-purpose solutions which enable pharmaceutical companies to shorten patient recruitment and save costs by streamlining operations and leveraging strategic intelligence. Clinerion’s proprietary Big Data analytics technologies leverage real-time data from electronic health records which comply with international patient privacy and data security regulations. Clinerion is a global data technology service company headquartered in Switzerland.
Clinerion website: www.clinerion.com
For more information, please contact:
Le Vin Chin
Director, Head of Marketing & Communications
Clinerion Ltd
Elisabethenanlage 11, 4051 Basel, Switzerland
Tel.: +41 61 865 60 54
About Georgian Medical Software – MEDSOFT
MEDSOFT is a Hospital Information System (HIS) vendor in Georgia. Current version of MEDWORK is intended for all five types of medical institutions: outpatient clinic, inpatient hospital, laboratory, aesthetic centre, dental clinic. More than 40 medical institutions are our customers in Georgia.
MEDSOFT website: www.medsoft.ge
For more information, please contact:
Archil Kapanadze
CEO, iHealth advisor
MEDSOFT – Georgia Medical Software LLC
Tel.: +995-598-108-168
Improving Relationships and Diversifying the Site Selection Process
April 17th 2025In this episode of the Applied Clinical Trials Podcast, Liz Beatty, co-founder and chief strategy officer, Inato, discusses a number of topics around site engagement including community-based sites, the role of technology in improving site/sponsor relationships, how increased operational costs are impacting the industry, and more.
Phase III SELECT-GCA Trial Results Lead to FDA Approval of Rinvoq for Giant Cell Arteritis
April 30th 2025Rinvoq (upadacitinib) becomes the first oral JAK inhibitor approved by the FDA for the treatment of giant cell arteritis in adults, following robust data from the Phase III SELECT-GCA trial demonstrating its efficacy in achieving sustained remission and reducing glucocorticoid exposure.
Behind the Buzz: Why Clinical Research Leaders Flock to SCOPE Summit
February 7th 2025In this episode, we meet with Micah Lieberman, Executive Conference Director for SCOPE Summit (Summit for Clinical Ops Executives) at Cambridge Innovation Institute. We will dive deep into the critical role of collaboration within the clinical research ecosystem. How do we bring together diverse stakeholders—sponsors, CROs, clinical trial tech innovators, suppliers, patients, sites, advocacy organizations, investors, and non-profits—to share best practices in trial design, program planning, innovation, and clinical operations? We’ll explore why it’s vital for thought leaders to step beyond their own organizations and learn from others, exchanging ideas that drive advancements in clinical research. Additionally, we’ll discuss the pivotal role of scientific conferences like SCOPE Summit in fostering these essential connections and collaborations, helping shape the future of clinical trials. Join us as we uncover how collective wisdom and cross-industry partnerships are transforming the landscape of clinical research.
